Brown Brothers Harriman & Co’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-161
Closed -$3K 1574
2022
Q3
$3K Hold
161
﹤0.01% 1406
2022
Q2
$3K Sell
161
-322
-67% -$5.73K ﹤0.01% 1226
2022
Q1
$8K Hold
483
﹤0.01% 1074
2021
Q4
$10 Hold
483
﹤0.01% 927
2021
Q3
$9 Sell
483
-133
-22% -$3.05K ﹤0.01% 925
2021
Q2
$17 Buy
616
+1
+0.2% +$28 ﹤0.01% 834
2021
Q1
$18 Hold
615
﹤0.01% 787
2020
Q4
$18K Sell
615
-1,360
-69% -$36.7K ﹤0.01% 801
2020
Q3
$48K Buy
1,975
+69
+4% +$1.49K ﹤0.01% 578
2020
Q2
$34K Sell
1,906
-485
-20% -$6.38K ﹤0.01% 620
2020
Q1
$19K Sell
2,391
-1,862
-44% -$21.3K ﹤0.01% 641
2019
Q4
$56K Sell
4,253
-1,768
-29% -$21.4K ﹤0.01% 643
2019
Q3
$72K Sell
6,021
-3,357
-36% -$62.1K ﹤0.01% 587
2019
Q2
$229K Sell
9,378
-3,828
-29% -$110K ﹤0.01% 373
2019
Q1
$421K Buy
+13,206
New +$469K ﹤0.01% 277

Other funds holding CVET

Brown Brothers Harriman & Co's CVET Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 161 shares — an estimated $3K sold.

Brown Brothers Harriman & Co first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $421K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 161 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Brown Brothers Harriman & Co first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Brown Brothers Harriman & Co's Covetrus, Inc. Common Stock position peaked at $421K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.